A recent report by medical watchdog Do No Harm has revealed that U.S. hospitals collectively profited $120 million from performing gender-altering procedures on minors. This staggering figure, gleaned from insurance claims, highlights the growing market for medical interventions aimed at children experiencing gender dysphoria. Between 2019 and 2023, approximately 14,000 minors were subjected to procedures ranging from puberty blockers to cross-sex hormones and irreversible surgeries, including mastectomies performed on patients as young as 14 years old.
“I will sign a law prohibiting child sexual mutilation in all 50 states. And on day one I will re-instate the Trump ban on transgenders in the military.”
— President TrumpWatch👇the entire speech: https://t.co/m7dgSE7fnT pic.twitter.com/UpVYAvZ0HG
— Real America’s Voice (RAV) (@RealAmVoice) June 25, 2023
These findings underscore a growing concern among conservative and medical communities about the ethics and long-term effects of such procedures on minors. The financial incentives for hospitals to perform these treatments raise questions about whether the medical industry is prioritizing profits over the well-being of children. The report reveals a troubling reality where the medicalization of gender dysphoria in children has become not only a cultural battleground but a lucrative industry.
Critics argue that hospitals have become too eager to push life-altering procedures on minors, who may not be psychologically or emotionally mature enough to make such decisions. The fact that hospitals have raked in millions from these surgeries has prompted backlash from those who believe these procedures should be reserved for adults, whose capacity for informed consent is fully developed. The rapid rise of these surgeries also reflects the influence of activist movements that promote gender identity ideology, often at the expense of rigorous scientific scrutiny.
The data compiled by Do No Harm has confirmed what many on the conservative side of the debate have feared: that children, particularly vulnerable and confused ones, are being rushed into medical treatments that carry significant long-term risks. Puberty blockers, cross-sex hormones, and surgeries such as mastectomies are irreversible procedures with lifelong consequences. This report presents a grim reminder of how far the healthcare industry has ventured into ideological territory, driven by both cultural pressures and financial incentives.
Do No Harm’s findings also shed light on the complex relationship between the medical industry and the insurance system, which facilitated this $120 million in revenue. The availability of insurance coverage for these procedures has played a key role in their proliferation. By making it easier for hospitals to bill for gender-altering procedures, the insurance system has indirectly fueled the demand for such interventions on minors. This financial dynamic raises ethical concerns about whether minors are being treated for genuine medical needs or whether hospitals are capitalizing on a controversial trend to boost their bottom line.
Conservatives and medical professionals who question the rush to offer gender-altering procedures on minors emphasize the importance of exploring alternative, non-invasive approaches to treating gender dysphoria in children. Psychological counseling and mental health support are often underutilized in favor of irreversible procedures, even though many children might naturally resolve their dysphoria without medical intervention. Yet, hospitals and advocacy groups pushing for early medical intervention frequently dismiss these concerns, arguing that immediate access to these treatments is necessary to prevent mental health crises among dysphoric children.
What remains largely ignored in the mainstream discussion is the growing body of research indicating that many children who experience gender dysphoria eventually desist, identifying with their biological sex as they mature. Rushing into medical treatments that alter a child’s body irreversibly not only risks long-term harm but denies these children the opportunity to navigate their dysphoria through non-invasive means. The current profit-driven system incentivizes hospitals to perform these procedures, often without considering the long-term psychological and physical health implications for the minors involved.
The report also highlights a disturbing trend of increasingly younger patients undergoing these irreversible procedures. The fact that 14-year-olds are receiving mastectomies, a procedure traditionally reserved for adults, signals a dangerous acceleration in how gender dysphoria is treated in the medical community. While proponents of these procedures argue that they are life-saving, critics counter that these claims lack substantial long-term evidence and may be driven more by political ideology than sound medical practice.
This latest revelation from Do No Harm should reignite the national conversation about the ethics of performing irreversible procedures on minors. Conservatives, who have long warned about the dangers of allowing children to make life-altering medical decisions, see this as a clear case of the medical industry exploiting vulnerable youth for profit. More oversight and caution are needed before hospitals and insurance companies are allowed to continue profiting from such controversial and life-altering procedures on minors.
Sponsors:
Huge Spring Sale Underway On MyPillow Products
Use Promo Code FLS At Checkout
Inflation Buster: Freedom From High-Cost Cell Plans (50% off first month with promo code: FLS)